Individual sensitivity to DNA damage induced by styrene in vitro: Influence of cytochrome P450, epoxide hydrolase and glutathione S-transferase genotypes

Toxicology

Volumn 186, Issue 1-2, 2003, Pages 131-141

  Laffon, Blanca ^a   Pérez Cadahía, Beatriz ^a   Pásaro, Eduardo ^a   Méndez, Josefina ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Comet assay; Cytochrome P450; Epoxide hydrolase; Genetic polymorphisms; Glutathione S transferase; Styrene

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; ISOENZYME; STYRENE;

ADULT; ARTICLE; CELL ISOLATION; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; COMET ASSAY; CYTOCHROME P-450 ENZYME SYSTEM; DNA DAMAGE; EPOXIDE HYDROLASES; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; STYRENE;

EID: 0037447571     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00729-1     Document Type: Article

References (48)

1. Ali-Osman F., Akande O., Antoun G., Mao J.-X., Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. J. Biol. Chem. 272:1997;10004-10012.
2. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res. 464:2000;65-76.
3. Bernardini S., Hirvonen A., Järventaus H., Norppa H. Influence of GSTM1 and GSTT1 genotypes on sister chromatid exchange induction by styrene in cultured human lymphocytes. Carcinogenesis. 23:2002;893-897.
4. Betti C., Davini T., Giannessi L., Loprieno N., Barale R. Microgel electrophoresis assay (comet test) and SCE analysis in human lymphocytes from 100 normal subjects. Mutat. Res. 307:1994;323-333.
5. Brockstedt U., Krajinovic M., Richer C., Mathonnet G., Sinnett D., Pfau W., Labuda D. Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferase (GSTs). Mutat. Res. 516:2002;41-47.
6. Carriere V., Berthou F., Baird S., Belloe C., Beaune P., de Waziers I. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics. 6:1996;203-211.
7. Cascorbi I., Brockmöller J., Roots I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 56:1996;4965-4969.
8. Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat. Res. 285:1993;35-44.
9. Fenech M., Holland N., Chang W.P., Zeiger E., Bonassi S. The human micronucleus project - an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat. Res. 428:1999;271-283.
10. Ghittori S., Maestri L., Imbriani M., Capodaglio E., Cavalleri A. Urinary excretion of specific mercapturic acids in workers exposed to styrene. Am. J. Ind. Med. 31:1996;636-644.
11. Guengerich F.P., Kim D.H., Iwasaki M. Comparison of levels of several human microsomal cytochrome P450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 256:1991;1189-1194.
12. Hasset C., Aicher L., Sidhu J.S., Omiecinski J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 3:1994;421-428.
13. Hasset C., Lin J., Carty C.L., Laurenzana E.M., Omiecinski C.J. Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Arch. Biochem. Biophys. 337:1997;275-283.
14. Henderson L., Wolfreys A., Fedyk J., Bourner C., Windebank S. The ability of the comet assay to discriminate between genotoxins and cytotoxins. Mutagenesis. 13:1998;89-94.
15. Hirvonen A., Husgafvel-Pursiainen K., Antilla S., Karjalainen A., Sorsa M., Vainio H. Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer. Pharmacogenetics. 2:1992;259-263.
16. Hoffmann G., Hecht S.S. Advances in tobacco carcinogenesis. Cooper C.S., Grover P.L. Chemical Carcinogenesis and Mutagenesis (I). 1990;63-102 Springer Verlag, Berlin.
17. IARC, 1994. Some industrial chemicals. IARC monographs on the evaluation of carcinogenic risks to humans, International Agency for Research on Cancer 60, Lyon.
18. Laffon B., Pásaro E., Méndez J. Genotoxic effects of styrene-7,8-oxide in human white blood cells: comet assay in relation to the induction of sister-chromatid exchanges and micronuclei. Mutat. Res. 491:2001;163-172.
19. Laffon B., Pásaro E., Méndez J. Effects of styrene-7,8-oxide over p53, p21, bcl-2 and bax expression in human lymphocyte cultures. Mutagenesis. 16:2001;127-132.
20. Laffon B., Pásaro E., Méndez J. DNA damage and repair in human leukocytes exposed to styrene-7,8-oxide measured by the comet assay. Toxicol. Lett. 126:2002;61-68.
21. Landi S., Frenzilli G., Milillo P.C., Cocchi L., Sbrana I., Scapoli C., Barale R. Spontaneous sister chromatid exchange and chromosome aberration frequency in humans: the familial effect. Mutat. Res. 444:1999;337-345.
22. Lin D.-X., Tang Y.-M., Peng Q., Lu S.-X., Ambrosone C.B., Kadllubar F.F. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferase T1, P1, and M1 and cytochrome P450 2E1. Cancer Epidemiol. Biomark. Prev. 7:1998;1013-1018.
23. Miller R.R., Newhook R., Poole A. Styrene production, use and human exposure. Crit. Rev. Toxicol. 24:1994;S1-S10.
24. Moller P., Knudsen L.E., Loft S., Wallin H. The comet assay as a rapid test in biomonitoring occupational exposure to DNA-damaging agents and effect of confounding factors. Cancer Epidemiol. Biomark. Prev. 9:2000;1005-1015.
25. Norppa H., Tursi F. Erythrocyte-mediated metabolic activation detected by SCE. Tice R.R., Hollaender A. Sister Chromatid Exchanges. 29B:1984;547-559 Plenum Press, New York.
26. Norppa H., Sorsa M. Genetic toxicity of 1,3-butadiene and styrene. Sorsa M., Peltonen K., Vainio H., Hemminki K. Butadiene and Styrene: Assessment of Health Hazards. 1993;185-193 IARC Scientific Publications, Lyon. No. 127.
27. Norppa H., Vainio H., Sorsa M. Metabolic activation of styrene by erythrocytes detected as increased sister chromatid exchanges in cultured human lymphocytes. Cancer Res. 43:1983;3579-3582.
28. Olive, P.L., Banath, J.P., Durand, R.E., 1990. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat. Res. 122, 86-94.
29. Palus J., Dziubaltowska E., Rydzynski K. DNA damage detected by the comet assay in the white blood cells of workers in a wooden furniture plant. Mutat. Res. 444:1999;61-74.
30. Pemble L., Schoreder K.R., Spencer S.R., Meyer K.J., Hallier E., Bolt H.M., Ketterer B., Taylor J.B. Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300:1994;271-276.
31. Persson I., Johansson I., Bergling H., Dahl M.L., Seidegard J., Rylander R., Rannug A., Hogberg J., Inglelman-Sundberg M. Genetic polymorphism of cytochrome P450IIE1 in a Swedish population. Relationship to incidence of lung cancer. FEBS Lett. 319:1993;207-211.
32. Pfäffli P., Säämänen A. The occupational scene of styrene. Sorsa M., Peltonen K., Vainio H., Hemminki K. Butadiene and Styrene: Assessment of Health Hazards. 1993;15-26 IARC Scientific Publications, Lyon. No. 127.
33. Raaka S., Hassett C., Omiecinski C.J. Human microsomal epoxide hydrolase: 5′-flanking region genetic polymorphisms. Carcinogenesis. 19:1998;387-393.
34. Saarikoski S.T., Voho A., Reinkainen M., Anttila S., Karjalainen A., Malaveille C., Vainio H., Husgafvel-Pursiainen K., Hirvonen A. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int. J. Cancer. 77:1998;516-521.
35. Sarmanová J., Týnková L., Süsová S., Gut I., Soucek P. Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic. Pharmacogenetics. 10:2000;781-788.
36. Scott D., Preston R.J. A re-evaluation of the cytogenetic effects of styrene. Mutat. Res. 318:1994;175-203.
37. Seidegard J., Pero R.W. The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum. Genet. 69:1985;66-68.
38. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175:1988;184-191.
39. Smith C.A.D., Harrison D.J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet. 350:1997;630-633.
40. Smith G., Stubbins M.J., Harries L.W., Wolf C.R. Molecular genetics of the human cytochrome P450 monooxygenase superfamily. Xenobiotica. 28:1998;1129-1165.
41. Sumner S.J., Fennell T.R. Review of the metabolic fate of styrene. Crit. Rev. Toxicol. 24:1994;S11-S33.
42. Tan W., Song N., Wang G.-Q., Liu Q., Tang H.-J., Kadlubar F.F., Lin D.-X. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol. Biomark. Prev. 9:2000;551-556.
43. Vodicka P., Soucek P., Tates A.D., Dusinska M., Sarmanova J., Zamecnikova M., Vodickova L., Koskinen M., de Zwart F.A., Natarajan A.T., Hemminki K. Association between genetic polymorphism and biomarkers in styrene-exposed workers. Mutat. Res. 482:2001;89-103.
44. Watanabe J., Hayashi S., Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. J. Biochem. 116:1994;321-326.
45. Welfare M., Adeokun A.M., Bassendine M.F., Daly A.K. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol. Biomark. Prev. 8:1999;289-292.
46. Wenker M.A.M., Kezic S., Monster A.C., de Wolff F.A. Metabolism of styrene-7,8-oxide in human liver in vitro: interindividual variation and stereochemistry. Toxicol. Appl. Pharmacol. 169:2000;52-58.
47. Zhang X., Chakrabarti S., Malick A.M., Richer C. Effects of different styrene metabolites on cytotoxicity, sister-chromatid exchanges and cell-cycle kinetics in human whole blood lymphocytes in vitro. Mutat. Res. 302:1993;213-218.
48. Zhu C.Q., Lam T.H., Jiang C.Q., Wei B.X., Lou X., Liu W.W., Lao X.Q., Chen Y.H. Lymphocyte DNA damage in cigarette factory workers measured by the Comet assay. Mutat. Res. 444:1999;1-6.